This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.


January 16, 2018
In this study with 663 TAVI patients, the authors investigated the predictors for next day discharge (NDD). After excluding cases that did not have a minimalist transfemoral approach, 150 patients had NDD and 210 patients had non-NDD.
January 5, 2018
A handy free, short, good quality video on an open valve-in valve procedure.
January 2, 2018
The authors compared mechanically expanded TAVR to self-expanding TAVR in a randomized non-inferiority trial.  Major adverse events occurred in 20% and 17% of patients, respectively (safety measure).  The one-year rates of mortality, stroke, or paravalvular leak for the valves were 15.4% and 25.5%, respectively (effectiveness measure).  Mechanically
December 26, 2017
The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) copublished the 2017 guidelines for the management of valvular disease in the European Heart Journal and in the European Journal of Cardio-Thoracic Surgery.
December 15, 2017
Patient Care A baby in the UK has surgery to put her ectopic heart back inside her chest.
December 14, 2017
Heyman Luckraz of the American Hospital Dubai, UAE, presents an overview of different access routes for transcatheter aortic valve replacement.
November 16, 2017
This brief article compares costs and morbidities for TAVR and SAVR in the current era.  TAVR costs are higher than for SAVR and have increased despite no apparent change in comorbidity index.  In contrast, SAVR costs remained stable during the same period.
November 7, 2017
Severe aortic regurgitation without calcification of the aortic annulus cannot be treated with transcatheter implantation of a balloon-expandable valve, however, self-expandable valves can be successfully anchored in the absence of annulus calcification.
October 20, 2017
Many answers need to be addressed before transcatheter aortic valve implantation (TAVI) is adopted in lower risk patients. This paper highlights the pros and cons of TAVI based mostly on randomized clinical trials involving the two device platforms approved in the United States.